dc.contributorRio Hortega University Hospital
dc.contributorKing Khaled Eye Specialist Hospital
dc.contributorMansoura Faculty of Medicine
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-12-11T17:17:00Z
dc.date.available2018-12-11T17:17:00Z
dc.date.created2018-12-11T17:17:00Z
dc.date.issued2017-09-14
dc.identifierCase Reports in Ophthalmology, v. 8, n. 3, p. 574-580, 2017.
dc.identifier1663-2699
dc.identifierhttp://hdl.handle.net/11449/175669
dc.identifier10.1159/000485498
dc.identifier2-s2.0-85038631005
dc.identifier2-s2.0-85038631005.pdf
dc.description.abstractPurpose: We report 6 patients who received a hydroxyapatite (HA) orbital implant in the socket and developed chronic orbital inflammation unresponsive to conventional medical therapy. Case Reports: We assisted 6 cases (4 males, 2 females) who received an HA orbital implant in the socket between 2015 and 2016 at King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, and developed chronic orbital inflammation with chronic discharge, redness, and pain (onset from weeks to over 2 decades after surgery). Computed tomography evaluation indicated inflammation in the orbital tissues, and histological examination showed a foreign body granulomatous reaction mainly localized around and blanching the HA implant. The condition was unresponsive to usual medical treatment and was resolved immediately after implant removal. Conclusions: Chronic inflammation can occur decades after placement of an HA implant in the orbit and can be successfully treated with implant removal.
dc.languageeng
dc.relationCase Reports in Ophthalmology
dc.relation0,333
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAnophthalmic cavity
dc.subjectChronic inflammatory reaction
dc.subjectHydroxyapatite
dc.subjectIntegrated implant
dc.titleChronic orbital inflammation associated to hydroxyapatite implants in anophthalmic sockets
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución